Skip to main content
SpringerLink
Log in

High-Risk Human Papillomaviruses and Epstein-Barr Virus Presence and Crosstalk in Human Oral Carcinogenesis

  • Chapter
  • First Online:
Development of Oral Cancer

Abstract

Oral cancer is the most frequent type of malignancy of the head and neck area worldwide. This cancer is a major cause of mortality in several parts of the world especially in certain Asian countries. In fact, the majority of cancer deaths are the result of metastasis, either directly due to tumor involvement of critical organs or indirectly due to therapeutic side effects. On the other hand, it is estimated that 10–20% of human cancers are linked to virus infections including Epstein-Barr virus (EBV) and high-risk human papillomaviruses (HPVs) especially types 16, 18, and 33, which cumulatively infect 80–90% of the population worldwide. Moreover, it has been reported that oncoproteins of high-risk HPV type 16 can covert noninvasive and nonmetastatic human cancer cells into invasive and metastatic form. It was pointed out that high-risk HPVs and EBV are important etiological factors in human oral cancer, since around 35 and 55% of these cancers are positive for these viruses, respectively. In addition, it was recently revealed that high-risk HPVs and EBV can be copresent in human oral cancer, and their copresence is associated with high-grade invasive carcinomas. Thus, it is evident that high-risk HPVs and EBV oncoproteins play an important role in the initiation and progression of human oral cancer. In this chapter, we will overview the presence and role of HPVs and EBV in this frequent malignancy, more specifically; we will focus on the role of their oncoproteins and their interactions with other oncogenes in human oral carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010;46:414–7.

    Article  PubMed  Google Scholar 

  2. Noguti J, De Moura CF, De Jesus GP, Da Silva VH, Hossaka TA, Oshima CT, Ribeiro DA. Metastasis from oral cancer: an overview. Cancer Genomics Proteomics. 2012;9:329–35.

    CAS  PubMed  Google Scholar 

  3. Al Moustafa AE, Chen D, Ghabreau L, Akil N. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. Med Hypotheses. 2009;73:184–6.

    Article  PubMed  Google Scholar 

  4. Okura M, Aikawa T, Sawai NY, Iida S, Kogo M. Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol. 2009;45:908–11.

    Article  PubMed  Google Scholar 

  5. Fan S, Tang QL, Lin YJ, Chen WL, Li JS, Huang ZQ, Yang ZH, Wang YY, Zhang DM, Wang HJ, et al. A review of clinical and histological parameters associated with contralateral neck metastases in oral squamous cell carcinoma. Int J Oral Sci. 2011;3:180–91.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lea J, Bachar G, Sawka AM, Lakra DC, Gilbert RW, Irish JC, Brown DH, Gullane PJ, Goldstein DP. Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Head Neck. 2010;32:184–90.

    PubMed  Google Scholar 

  7. Farris C, Petitte DM. Head, neck, and oral cancer update. Home Healthc Nurse. 2013;31:322–8; quiz 328-330

    Article  PubMed  Google Scholar 

  8. Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol. 2011;23:633–41.

    Article  PubMed  Google Scholar 

  9. Higa M, Kinjo T, Kamiyama K, Chinen K, Iwamasa T, Arasaki A, Sunakawa H. Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan—simultaneously infected with human papillomavirus (HPV). Oral Oncol. 2003;39:405–14.

    Article  PubMed  Google Scholar 

  10. Jalouli J, Ibrahim SO, Sapkota D, Jalouli MM, Vasstrand EN, Hirsch JM, Larsson PA. Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use. J Oral Pathol Med. 2010;39:599–604.

    Article  CAS  PubMed  Google Scholar 

  11. Jalouli J, Jalouli MM, Sapkota D, Ibrahim SO, Larsson PA, Sand L. Human papilloma virus, herpes simplex virus and Epstein Barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Res. 2012;32:571–80.

    CAS  PubMed  Google Scholar 

  12. Jiang R, Ekshyyan O, Moore-Medlin T, Rong X, Nathan S, Gu X, Abreo F, Rosenthal EL, Shi M, Guidry JT, et al. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med. 2015;44:28–36.

    Article  CAS  PubMed  Google Scholar 

  13. Al Moustafa AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L, Alaoui-Jamali MA. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene. 2004;23:350–8.

    Article  PubMed  Google Scholar 

  14. Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303–15.

    Article  PubMed  Google Scholar 

  15. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621–32.

    Article  CAS  PubMed  Google Scholar 

  16. Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16–26 years. J Infect Dis. 2009;199:926–35.

    Article  PubMed  Google Scholar 

  17. Darus CJ, Mueller JJ. Development and impact of human papillomavirus vaccines. Clin Obstet Gynecol. 2013;56:10–6.

    Article  PubMed  Google Scholar 

  18. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14.

    Article  CAS  PubMed  Google Scholar 

  19. Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer. 2011;129:433–9.

    Article  CAS  PubMed  Google Scholar 

  20. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.

    Article  CAS  PubMed  Google Scholar 

  21. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, Das BC. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res. 2009;130:222–33.

    CAS  PubMed  Google Scholar 

  22. Umudum H, Rezanko T, Dag F, Dogruluk T. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas. Cancer. 2005;105:171–7.

    Article  PubMed  Google Scholar 

  23. Varnai AD, Bollmann M, Griefingholt H, Speich N, Schmitt C, Bollmann R, Decker D. HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Color Dis. 2006;21:135–42.

    Article  CAS  Google Scholar 

  24. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813–20.

    Article  CAS  PubMed  Google Scholar 

  25. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007). Ann Oncol. 2008;19:1681–90.

    Article  CAS  PubMed  Google Scholar 

  26. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res. 2004;23:561–6.

    CAS  PubMed  Google Scholar 

  27. Doorbar J. The papillomavirus life cycle. J Clin Virol. 2005;32(Suppl 1):S7–15.

    Article  CAS  PubMed  Google Scholar 

  28. Grm HS, Massimi P, Gammoh N, Banks L. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene. 2005;24:5149–64.

    Article  PubMed  Google Scholar 

  29. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10:550–60.

    Article  CAS  PubMed  Google Scholar 

  30. Kim SH, Juhnn YS, Kang S, Park SW, Sung MW, Bang YJ, Song YS. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt. Cell Mol Life Sci. 2006;63:930–8.

    Article  CAS  PubMed  Google Scholar 

  31. Suprynowicz FA, Disbrow GL, Krawczyk E, Simic V, Lantzky K, Schlegel R. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene. 2008;27:1071–8.

    Article  CAS  PubMed  Google Scholar 

  32. Stacey SN, Jordan D, Williamson AJ, Brown M, Coote JH, Arrand JR. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. J Virol. 2000;74:7284–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B, Tommasino M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes. 2010;40:1–13.

    Article  CAS  PubMed  Google Scholar 

  34. Herber R, Liem A, Pitot H, Lambert PF. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol. 1996;70:1873–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Song S, Pitot HC, Lambert PF. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol. 1999;73:5887–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Riley RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res. 2003;63:4862–71.

    CAS  PubMed  Google Scholar 

  37. Genther Williams SM, Disbrow GL, Schlegel R, Lee D, Threadgill DW, Lambert PF. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 2005;65:6534–42.

    Article  CAS  PubMed  Google Scholar 

  38. Stelzer MK, Pitot HC, Liem A, Schweizer J, Mahoney C, Lambert PF. A mouse model for human anal cancer. Cancer Prev Res (Phila). 2010;3:1534–41.

    Article  CAS  Google Scholar 

  39. Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol. 2001;82:149–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Munz C, Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol. 2008;18:381–7.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10:803–21.

    Article  CAS  PubMed  Google Scholar 

  42. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A. 1998;95:11963–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Murata T, Tsurumi T. Switching of EBV cycles between latent and lytic states. Rev Med Virol. 2014;24:142–53.

    Article  CAS  PubMed  Google Scholar 

  44. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.

    Article  CAS  PubMed  Google Scholar 

  45. Aboulkassim T, Yasmeen A, Akil N, Batist G, Al Moustafa AE. Incidence of Epstein-Barr virus in Syrian women with breast cancer: a tissue microarray study. Hum Vaccin Immunother. 2015;11:951–5.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Amarante MK, Watanabe MA. The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol. 2009;135:329–37.

    Article  PubMed  Google Scholar 

  47. Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol. 2012;22:144–53.

    Article  CAS  PubMed  Google Scholar 

  48. Michelow P, Wright C, Pantanowitz L. A review of the cytomorphology of Epstein-Barr virus-associated malignancies. Acta Cytol. 2012;56:1–14.

    Article  PubMed  Google Scholar 

  49. Morris MA, Dawson CW, Young LS. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol. 2009;5:811–25.

    Article  CAS  PubMed  Google Scholar 

  50. Babu KG. Oral cancers in India. Semin Oncol. 2001;28:169–73.

    Article  CAS  PubMed  Google Scholar 

  51. Ng RH, Ngan R, Wei WI, Gullane PJ, Phillips J. Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 2014;150:602–9.

    Article  PubMed  Google Scholar 

  52. Popat SR, Liavaag PG, Morton R, McIvor N, Irish JC, Freeman JL. Epstein Barr virus genome in nasopharyngeal carcinomas from New Zealand. Head Neck. 2000;22:505–8.

    Article  CAS  PubMed  Google Scholar 

  53. Whitney BM, Chan AT, Rickinson AB, Lee SP, Lin CK, Johnson PJ. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients. J Med Virol. 2002;67:359–63.

    Article  CAS  PubMed  Google Scholar 

  54. Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O’Sullivan B, Bastianutto C, et al. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res. 2006;12:5726–32.

    Article  CAS  PubMed  Google Scholar 

  55. Curran JA, Laverty FS, Campbell D, Macdiarmid J, Wilson JB. Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Res. 2001;61:6730–8.

    CAS  PubMed  Google Scholar 

  56. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell. 1990;61:1315–27.

    Article  CAS  PubMed  Google Scholar 

  57. Charalambous CT, Hannigan A, Tsimbouri P, McPhee GM, Wilson JB. Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF alpha prior to neoplasia. Carcinogenesis. 2007;28:1839–48.

    Article  CAS  PubMed  Google Scholar 

  58. Stevenson D, Charalambous C, Wilson JB. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Res. 2005;65:8826–35.

    Article  CAS  PubMed  Google Scholar 

  59. Shair KH, Raab-Traub N. Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma. MBio. 2012;3:e00288–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Al Moustafa AE, Al-Awadhi R, Missaoui N, Adam I, Durusoy R, Ghabreau L, Akil N, Ahmed HG, Yasmeen A, Alsbeih G. Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle East and North African regions. Hum Vaccin Immunother. 2014;10:1812–21.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Al Moustafa AE, Ghabreau L, Akil N, Rastam S, Alachkar A, Yasmeen A. High-risk HPVs and human carcinomas in the Syrian population. Front Oncol. 2014;4:68.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene. 2002;21:2634–40.

    Article  CAS  PubMed  Google Scholar 

  63. Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu Q, Herlyn M, Sicinski P, Alaoui-Jamali MA. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene. 2004;23:5252–6.

    Article  PubMed  Google Scholar 

  64. Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez PY, Al Moustafa AE. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle. 2007;6:2038–42.

    Article  CAS  PubMed  Google Scholar 

  65. Al Moustafa AE, Kassab A, Darnel A, Yasmeen A. High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis. Curr Pharm Des. 2008;14:2159–72.

    Article  PubMed  Google Scholar 

  66. Al Moustafa AE, Yasmeen A, Ghabreau L, Akil N. Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine? Hum Vaccin Immunother. 2012;8:1867–8.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–4.

    Article  CAS  PubMed  Google Scholar 

  68. Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol. 2014;50:565–74.

    Article  PubMed  Google Scholar 

  69. Guidry JT, Scott RS. The interaction between human papillomavirus and other viruses. Virus Res. 2016;231:139–47.

    Article  PubMed  Google Scholar 

  70. Dahlstrom KR, Adler-Storthz K, Etzel CJ, Liu Z, Dillon L, El-Naggar AK, Spitz MR, Schiller JT, Wei Q, Sturgis EM. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003;9:2620–6.

    PubMed  Google Scholar 

  71. Polz-Gruszka D, Morshed K, Stec A, Polz-Dacewicz M. Prevalence of human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in South-Eastern Poland. Infect Agent Cancer. 2015;10:37.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Nielsen NH, Mikkelsen F, Hansen JP. Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population. Acta Pathol Microbiol Scand A. 1977;85:850–8.

    CAS  PubMed  Google Scholar 

  73. Henle W, Henle G, Zajac BA, Pearson G, Waubke R, Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970;169:188–90.

    Article  CAS  PubMed  Google Scholar 

  74. Ji MF, Wang DK, Yu YL, Guo YQ, Liang JS, Cheng WM, Zong YS, Chan KH, Ng SP, Wei WI, et al. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer. 2007;96:623–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Deng Z, Uehara T, Maeda H, Hasegawa M, Matayoshi S, Kiyuna A, Agena S, Pan X, Zhang C, Yamashita Y, et al. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers. PLoS One. 2014;9:e113702.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Laantri N, Attaleb M, Kandil M, Naji F, Mouttaki T, Dardari R, Belghmi K, Benchakroun N, El Mzibri M, Khyatti M. Human papillomavirus detection in Moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer. 2011;6:3.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Mirzamani N, Salehian P, Farhadi M, Tehran EA. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization. Exp Mol Pathol. 2006;81:231–4.

    Article  CAS  PubMed  Google Scholar 

  78. Tung YC, Lin KH, Chu PY, Hsu CC, Kuo WR. Detection of human papilloma virus and Epstein-Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction. Kaohsiung J Med Sci. 1999;15:256–62.

    CAS  PubMed  Google Scholar 

  79. Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY, Worden FP, Wolf GT, Chepeha DB, Prince ME, et al. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014;88:580–8.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Dogan S, Hedberg ML, Ferris RL, Rath TJ, Assaad AM, Chiosea SI. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2014;36:511–6.

    Article  PubMed  Google Scholar 

  81. Lin Z, Khong B, Kwok S, Cao H, West RB, Le QT, Kong CS. Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients. Head Neck. 2014;36:709–14.

    Article  PubMed  Google Scholar 

  82. Lo EJ, Bell D, Woo J, Li G, Hanna EY, El-Naggar AK, Sturgis EM. Human papillomavirus & WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010;120(Suppl 4):S185.

    Article  PubMed  Google Scholar 

  83. Maxwell JH, Kumar B, Feng FY, Worden FP, Lee JS, Eisbruch A, Wolf GT, Prince ME, Moyer JS, Teknos TN, et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010;16:1226–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Robinson M, Suh YE, Paleri V, Devlin D, Ayaz B, Pertl L, Thavaraj S. Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agent Cancer. 2013;8:30.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Al Moustafa AE, Achkhar A, Yasmeen A. EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. Front Biosci (Schol Ed). 2012;4:671–84.

    Article  Google Scholar 

Download references

Acknowledgments

We are grateful to Mrs. A. Kassab for her critical reading of the chapter. Our research works are supported by Qatar University and its College of Medicine Grant #: GCC-2017-002 QU/KU.

Author information

Authors and Affiliations

  1. College of Medicine & Biomedical Research Centre, Qatar University, Doha, Qatar

    Ala-Eddin Al Moustafa, Farhan S. Cyprian & Noor Al-Antary

  2. Oncology Department, McGill University, Montreal, QC, Canada

    Ala-Eddin Al Moustafa & Amber Yasmeen

  3. Syrian Research Cancer Centre of the Syrian Society Against Cancer, Aleppo, Syria

    Ala-Eddin Al Moustafa

Authors
  1. Ala-Eddin Al Moustafa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farhan S. Cyprian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noor Al-Antary
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amber Yasmeen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ala-Eddin Al Moustafa .

Editor information

Editors and Affiliations

  1. Department of Basic Medical Science, Qatar University/College of Medicine, Doha, Qatar

    Ala-Eddin Al Moustafa

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Al Moustafa, AE., Cyprian, F.S., Al-Antary, N., Yasmeen, A. (2017). High-Risk Human Papillomaviruses and Epstein-Barr Virus Presence and Crosstalk in Human Oral Carcinogenesis. In: Al Moustafa, AE. (eds) Development of Oral Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-48054-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48054-1_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48053-4

  • Online ISBN: 978-3-319-48054-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation